Skip to main content
OpenTrials
Enrolling by Invitation

NCT Number: NCT07621757

The Implementation of Genetic Risk for Colorectal Cancer Screening

The goal of this study is to investigate genetic risk for colorectal cancer utilizing polygenic risk scores (PRS) for adults over 45 who have not received their first colonoscopy. The main questions it hopes to address are:

1. How does knowledge of a patient's genetic risk for colorectal cancer affect the uptake of initial screening colonoscopies? 2. How do colonoscopy outcomes compare between genetic risk groups?

Enrolling by Invitation

Interested in participating?

Request Info

Key information

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Due for initial screening colonoscopy per current guidelines

Exclusion criteria

  • Prior colonoscopy
  • Prior personal history of colorectal cancer or inflammatory bowel disease
  • Medical contraindications to colonoscopy/sedation

Treatment and study plan

Primary outcomes

  1. Number of scheduled colonoscopies in each genetic risk group

    Time frame: One year following enrollment

Secondary outcomes

  1. Number of polyps and/or adenomas found through colonoscopy in each genetic risk group

    Time frame: One year following enrollment

Sponsors and collaborators

Lead sponsor

Endeavor Health

Other

Registry information

Official study title

Prospective Trial for the Implementation of Genetic Risk for Colorectal Cancer Screening

Acronym: PRO-GENE-COLON

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jun 2, 2026
Registry last updated
Jun 2, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.